Denosumab and MRI Breast Imaging

NCT02613416 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Denosumab

Sponsor

Alison Stopeck

Collaborators

[object Object]